TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.

Paul F Robbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.